cerca CERCA
Mercoledì 21 Aprile 2021
Aggiornato: 06:15
Temi caldi

CHIMICA E FARMACEUTICA

European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations

DARMSTADT, Germany, Nov. 26, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition factor gene (MET) exon 14 (METex14) skipping alterations. With this validation, the application is complete, and the EMA will now begin the review procedure. 

MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients

NYON, Switzerland, Nov. 25, 2020 /PRNewswire/ -- MedAlliance has announced completion of patient enrolment in the ISABELLA Clinical Trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodialysis. SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to a drug-eluting stent (DES).

3D bioprinted heart provides new tool for surgeons

PITTSBURGH, Nov. 19, 2020 /PRNewswire/ -- Carnegie Mellon University Professor of Biomedical Engineering Adam Feinberg and his team have created the first full-size 3D bioprinted human heart model using their Freeform Reversible Embedding of Suspended Hydrogels (FRESH) technique. Showcased in a recent video by American Chemical Society and created from MRI data using a specially built 3D printer, the model mimics the elasticity of cardiac tissue and sutures realistically. This milestone represent...

Ascend introduces HiDura™ long-chain polyamides

HOUSTON, Nov. 17, 2020 /PRNewswire/ -- Ascend Performance Materials has launched several new grades of its HiDura™ long-chain polyamides for engineered plastics, monofilaments and cable ties. HiDura polyamide 610 and 612 are designed to provide exceptional dimensional stability and long life with enhanced resistance to chemicals, impact and abrasion.

Late-Breaking Study Results of the Supreme HT™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety

TIANJIN, China, Nov. 17, 2020 /PRNewswire/ -- SINOMED® today announced that Prof. Alexandra Lansky from the Yale School of Medicine, USA, presented data from its first inter-continental PIONEER III study comparing the safety and efficacy of the Supreme HT (Healing-Targeted) Drug-Eluting Stent, to the Xience or Promus Durable Polymer Drug-Eluting Stent (DP DES).  One-year results, revealed at the 2020 American Heart Association Scientific Late-Breaking Trials Session, showed equivalent clinical pe...

WuXi Biologics adopt Purolite Life Sciences Protein A resin for monoclonal antibody therapies

CARDIFF, South Wales, Nov. 5, 2020 /PRNewswire/ -- Purolite Ltd., a global manufacturer of resin-based separation, purification and extraction technologies, today announces that it will supply its Protein A capture resin, Praesto® Jetted A50 to WuXi Biologics for immediate use. WuXi Biologics, a global company with leading open-access biologics technology, will utilize Praesto® Jetted A50 to provide their customers with additional choices for affinity chromatography resins for a range of downstre...

ora in
Prima pagina
Tag più usati
in questa pagina

change in emea region

executive

leadership

leadership change

partner di canale

prodotti imdsoft

servizi metavision

sistema informativo

articoli
in Evidenza